ASX - By Stock
|
ADR |
Re:
Ann: AstraZeneca selected Adherium Smartinhaler for its study
|
|
Hharry
|
35 |
8.9K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
35
|
8.9K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Non-Renounceable Rights Issue Offer Completes
|
|
Hharry
|
7 |
1.2K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
7
|
1.2K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Attending American Thoracic Society International Conference
|
|
Hharry
|
7 |
1.9K |
4 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
7
|
1.9K
|
4
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Entitlement Offer Opens and Letters to Shareholders
|
|
Hharry
|
13 |
3.5K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Change in substantial holding
|
|
Hharry
|
3 |
873 |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
3
|
873
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Entitlement Offer Opens and Letters to Shareholders
|
|
Hharry
|
13 |
3.5K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Entitlement Offer Opens and Letters to Shareholders
|
|
Hharry
|
13 |
3.5K |
2 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
13
|
3.5K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Entitlement Offer Opens and Letters to Shareholders
|
|
Hharry
|
13 |
3.5K |
0 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
13
|
3.5K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Entitlement Offer Opens and Letters to Shareholders
|
|
Hharry
|
13 |
3.5K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Investor Presentation
|
|
Hharry
|
38 |
12K |
1 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
38
|
12K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Hharry
|
558 |
182K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
558
|
182K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Investor Presentation
|
|
Hharry
|
38 |
12K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
38
|
12K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Hharry
|
236 |
91K |
9 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
91K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Hharry
|
236 |
91K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
91K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Disclosure of Long Equity Derivative Positions
|
|
Hharry
|
27 |
9.8K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
27
|
9.8K
|
4
|
|
Charts
|
MSB |
Re:
chart
|
|
Hharry
|
67 |
33K |
3 |
17/04/24 |
17/04/24 |
Charts
|
67
|
33K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Proposed issue of securities - MSB
|
|
Hharry
|
18 |
5.8K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
18
|
5.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Proposed issue of securities - MSB
|
|
Hharry
|
18 |
5.8K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
18
|
5.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Hharry
|
5.3K |
2.6M |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
Hharry
|
185 |
46K |
11 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
185
|
46K
|
11
|
|
ASX - Day Trading
|
|
Re:
Day trading pre-market open September 16
|
|
Hharry
|
125 |
34K |
1 |
16/09/20 |
16/09/20 |
ASX - Day Trading
|
125
|
34K
|
1
|
|
ASX - By Stock
|
CXZ |
Re:
Ann: Change of Director's Interest Notice
|
|
Hharry
|
40 |
12K |
0 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
CXZ |
Re:
Earnings increasing & multiples expanding (Re-rate commencing)
|
|
Hharry
|
1.3K |
375K |
5 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
1.3K
|
375K
|
5
|
|
ASX - By Stock
|
CXZ |
Re:
Technical Analysis (TA) Thread: 10c target (c.$85m MC)
|
|
Hharry
|
151 |
53K |
7 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
151
|
53K
|
7
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Reports Neutralizing activity Against SARS-CoV-2
|
|
Hharry
|
628 |
194K |
0 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
628
|
194K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
5 |
19/06/20 |
19/06/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
|
|
Hharry
|
143 |
71K |
13 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
143
|
71K
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
5 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
3 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
1 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
1 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
0 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
0 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
0 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
6 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
8 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
Hharry
|
182 |
67K |
0 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
182
|
67K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
Hharry
|
182 |
67K |
3 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
182
|
67K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
Hharry
|
182 |
67K |
1 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
182
|
67K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
Hharry
|
182 |
67K |
1 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
182
|
67K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
Hharry
|
182 |
67K |
13 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
182
|
67K
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
0 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Hharry
|
23K |
13M |
3 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO ... how will americans respond?
|
|
Hharry
|
59 |
30K |
5 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
59
|
30K
|
5
|
|